USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Smoking Cessation Drug Market
U.S. Smoking Cessation Drug Market
RELEASE DATE
19-Dec-2007
19-Dec-2007
REGION
North America
North America
Research Code: N2DE-01-00-00-00
SKU: HC02058-NA-MR_07441
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02058-NA-MR_07441
Description
This research service covers the U.S. smoking cessation drug market from 2003-2013. Included are a therapeutic overview, patient forecasts, total market revenue forecasts, product revenue forecasts, and market share analysis. The market is segmented by product: Zyban, Chantix, and emerging products. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.
Table of Contents
Executive Summary
- Introduction
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Smoking Overview
- Introduction
- Smoking Statistics
- Components of Cigarettes
- Reasons To Quit Smoking
- Health Risks of Smoking
- Health Benefits from Quitting Smoking
- Treatment Options
Market Overview
- Market Engineering Measurements
- Industry Challenges
- Market Drivers
- Market Restraints
Competitive Analysis
Product Analysis
Emerging Products
- Competitive Structure
Patient Forecasts
- Zyban
- Chantix
Revenue Forecasts
- Emerging Smoking Cessation Drugs
- Emerging Smoking Cessation Vaccines
Market Share Analysis
- Patient Forecasts
Decision Support Databases
This research service covers the U.S. smoking cessation drug market from 2003-2013. Included are a therapeutic overview, patient forecasts, total market revenue forecasts, product revenue forecasts, and market share analysis. The market is segmented by product: Zyban, Chantix, and emerging products. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | N2DE-01-00-00-00 |
| Is Prebook | No |